Monopar Therapeutics
MNPR
#8837
Rank
โ‚ฌ83.04 M
Marketcap
15,74ย โ‚ฌ
Share price
7.31%
Change (1 day)
811.36%
Change (1 year)

Monopar Therapeutics (MNPR) - Cash on Hand

Cash on Hand as of June 2024 : โ‚ฌ6.63 Million

According to Monopar Therapeutics's latest financial reports the company has โ‚ฌ6.63 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Monopar Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚ฌ12.23 M-31.78%
2021-12-31โ‚ฌ17.92 M31.75%
2020-12-31โ‚ฌ13.6 M15.36%
2019-12-31โ‚ฌ11.79 M95.77%
2018-12-31โ‚ฌ6.02 M-19.51%
2017-12-31โ‚ฌ7.48 M279.91%
2016-12-31โ‚ฌ1.97 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.26 B 3,923.25%๐Ÿ‡บ๐Ÿ‡ธ USA